Rapid Medical™ successfully completes ischemic stroke surgery using world's first robotic thrombectomy device

Wednesday, May 15, 2024

Rapid Medical ™ , a leading developer of advanced neurovascular devices, announced the first successful robotic thrombectomy in Medellin, Colombia. Two patients were treated with the robotic TIGERTRIEVER™ , the first endovascular thrombectomy device capable of autonomously adapting to the patient's anatomy.

"Automated stroke surgery is a major advance in medicine," stressed Dr. Boris Pabón, who performed the first-in-human surgery . Boris, an endovascular neurosurgeon in Angiosur , said, "Robotic thrombus removal achieves a precision that exceeds interventional capabilities. The robotic TIGERTRIEVER allows me to directly understand the characteristics of the patient's blood vessels and brings sensory capabilities that were previously unavailable, which is truly remarkable. amazing."

At the touch of a button, the AI-activated TIGERTRIEVER catches clogs with its active collection feature. The device's radial force then automatically reduces, minimizing trauma to the brain during retrieval. This relies on the excellent clinical results and surgical time brought about by the TIGERTRIEVER adjustability, and further improves precision and simplifies the surgical process.

“The implementation of this technology demonstrates our commitment to expanding care for stroke patients around the world,” said Ronen Eckhouse , CEO of Rapid Medical . “We have led advances in patient care, pioneering proactive technology for physicians and now enabling it through intelligent controls. Surgery automation explores a new path.”

About Rapid Medical

Rapid Medical expands the possibilities for neurovascular treatment by exploring advanced interventional devices for the treatment of ischemic and hemorrhagic stroke. Rapid Medical's products use proprietary manufacturing techniques that are remotely adjustable and fully visible. This allows doctors to respond to anatomy in real time and tailor treatments to each patient, resulting in better surgical outcomes. TIGERTRIEVER™ 13 , 17 and 21 , COMANECI ™ and COLUMBUS™/DRIVEWIRE are CE marked and FDA approved. TIGERTRIEVER XL also has the CE certification mark. For more information, please visit www.rapid-medical.com .

Disclaimer: The original version of this announcement is the officially authorized version. The translation is for convenience of understanding only. Please refer to the original text. The original version is the only legally binding version.

Contacts
Ronen Eckhouse
+972-72-2503331
ronen@rapid-medical.com




Source: businesswire.com